Byooviz

Indicated For

Neovascular (Wet) Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Retinopathy, Myopic Choroidal Neovascularization

About This Medication

# Biogen Copay Program Patient Guide: How to Get Byooviz (ranibizumab-nuna) at Low or No Cost Byooviz (ranibizumab-nuna) is an FDA-approved biosimilar to Lucentis, used to treat serious eye conditions like neovascular age-related macular degeneration (wet AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV). The **Biogen Copay Program** helps eligible commercially insured patients reduce out-of-pocket costs for Byooviz injections, potentially to as low as $0, depending on eligibility and program terms. ## About Byooviz (ranibizumab-nuna) **Byooviz** is a prescription eye injection given by an ophthalmologist directly into the eye (intravitreal injection). It works by blocking vascular endothelial growth factor (VEGF), a protein that causes abnormal blood vessel growth and leakage in the retina, leading to vision loss[1][2]. It's indicated for: - **Neovascular (wet) AMD**: Blurs or destroys central vision[2]. - **Macular edema after RVO**: Swelling in the eye's back from blocked retinal veins[2]. - **mCNV**: Abnormal blood vessels due to severe nearsightedness[1]. Typical dosing starts with monthly injections (0.5 mg/0.05 mL for wet AMD), sometimes shifting to every 3 months after initial doses. Your doctor determines the schedule based on response[2][3][7]. It's a **biosimilar** to Lucentis (ranibizumab), meaning it's highly similar with no clinically meaningful differences and can often be substituted at the pharmacy[1]. **Important safety note**: Byooviz is given only under doctor supervision. Risks include infection, retinal detachment, or vision changes—report symptoms immediately[3]. ## Who Qualifies for the Biogen Copay Program? This program from **Biogen** (Byooviz manufacturer) targets patients with **commercial insurance** facing high copays or coinsurance[4]. **Key eligibility**: - Prescription for Byooviz from your doctor. - **Commercial/private insurance only**—excludes Medicare, Medicaid, VA/DoD, or other federal plans[provided data]. - Likely income-based (common for copay programs), though exact thresholds aren't specified publicly; call 1-877-422-8360 to confirm[4]. - U.S. resident, 18+ (adult indication). **Income Eligibility Breakdown** Specific Federal Poverty Level (FPL) limits aren't detailed online, but Biogen programs often cover up to 400-500% FPL or cap assistance at income levels. Contact Biogen for personalized review. Here's a general table based on 2026 U.S. FPL guidelines (adjusts annually; verify current): | Household Size | 400% FPL Example | 500% FPL Example | Notes | |----------------|-------------------|-------------------|-------| | Individual | ~$60,000 | ~$75,000 | Common threshold range | | Couple | ~$81,000 | ~$101,000 | Add ~$21K per extra person | | Family of 3 | ~$102,000 | ~$127,000 | Biogen confirms exact | | Family of 4 | ~$123,000 | ~$154,000 | Call for details | *Table illustrative; program may have no strict FPL or use copay caps instead.*[4] ## Insurance Requirements **Commercial insurance only**—program **excludes Medicare, Medicaid, VA/DoD, federal plans, or uninsured patients**[provided data][4]. If government-insured, explore state aid or manufacturer patient assistance (separate from copay). Verify coverage; Byooviz may require prior authorization showing intolerance/contraindication to cheaper options like bevacizumab[5][6]. ## Step-by-Step Application Process 1. **Get Prescribed**: Ask your ophthalmologist for Byooviz. Discuss if biosimilar substitution for Lucentis is appropriate[1]. 2. **Check Eligibility**: Call **Biogen Biosimilar Support at (877) 422-8360** (Mon-Fri, business hours). Provide insurance details, income (if asked), and diagnosis[4][provided data]. 3. **Enroll**: Separate enrollment for **Drug Copay Program** (medication cost) and **Administration Copay** (injection fees). They'll guide you—online portal or phone[4]. 4. **Submit Documents**: Likely needs proof of income (tax return, paystubs), insurance card, prescription, doctor's note. Exact list confirmed on call[provided data]. 5. **Receive Copay Card**: Digital/physical card for pharmacy or doctor's office. Covers copays/coinsurance up to program max (e.g., $15K/year, typical). 6. **Use at Visit**: Present card at injection appointment. Program pays provider/pharmacy directly. **Pro Tip**: Enroll before first injection to avoid upfront costs. ## Timeline and Delivery - **Processing**: 1-3 business days typical for copay programs; call confirms[4]. - **Delivery**: No home delivery—Byooviz is doctor-administered. Copay covers pharmacy/office charges. Injections monthly at clinic[2][3]. - **Refills**: Auto via card; reauthorization may apply yearly or per guidelines. ## Alternatives if Denied or Ineligible - **Reference Product**: **Lucentis (ranibizumab)**—Byooviz biosimilar alternative; similar programs via Genentech (1-888-249-4918)[provided data]. - **Other Biosimilars**: Cimerli or others if available. - **Cheaper Option**: Bevacizumab (Avastin off-label)—often first-line, but requires compounding[5][6]. - **Government Insured**: State Medicaid (e.g., Louisiana PA criteria)[5], Medicare Extra Help, or NeedyMeds.org. - **Appeal**: Resubmit with more docs or doctor letter. - **Free Clinics**: Patient Access Network (PAN) Foundation or RxAssist.org. ## Disclaimer This guide is for informational purposes based on available data as of 2026. **Program terms change**—eligibility, coverage, and limits set by Biogen. Not medical/financial advice. Consult your doctor, insurer, and Biogen at (877) 422-8360. Biogen may discontinue anytime. Costs vary by insurance/deductibles. **Full 925 words.**

Program information last verified: March 30, 2026